Clinical Trial

SNAG and SNME in Non-Specific Sciatic Pain

Study acronym: CASE-SNAG
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is designed as a crossover trial. All participants who meet the inclusion criteria and voluntarily agree to participate will be evaluated using the assessment methods detailed below. Subsequently, participants will be randomly assigned into two groups. The first group (Mulligan Concept Group - MCG) will receive the SNAG technique, while the second group (Neural Mobilization Group - NMG) will perform the Sciatic Nerve Mobilization Exercise (SNME). After the intervention, participants will be evaluated a second time. Ten days after this session, participants will be invited back. Those who were in the MCG group during the first session will be re-evaluated and then receive the SNGE intervention. Participants who were in the SNGE group during the first session will be re-evaluated and then receive the SNAG intervention. Following this second intervention, participants will be evaluated once again. Assessments will be done are Demographic Form, Visual Analogue Scale, Oswestry Disability Index, Joint Range of Motion, Five-times Sit-to-stand Test, Sit and Reach Test
Trial Details
NCT Number NCT07161323
Lead Sponsor Istinye University
Conditions Sciatica Pain, Sciatica Acute, Mulligan Mobilization
Enrollment 30 participants
Start Date 2025-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-08